David Bibi

ORCID: 0000-0003-4018-7925
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Cholinesterase and Neurodegenerative Diseases
  • Neuroscience and Neuropharmacology Research
  • Enzyme function and inhibition
  • Pharmacological Effects and Toxicity Studies
  • Celiac Disease Research and Management
  • Lymphadenopathy Diagnosis and Analysis
  • Hematological disorders and diagnostics
  • Antibiotics Pharmacokinetics and Efficacy
  • Iron Metabolism and Disorders
  • Pesticide Exposure and Toxicity
  • Ion channel regulation and function
  • Immunodeficiency and Autoimmune Disorders
  • Drug Transport and Resistance Mechanisms

Hebrew University of Jerusalem
2016-2021

Abderrahmane Mami Hospital
2007

Summary Objectives Children and adults are likely to be among the casualties in a civilian nerve agent exposure. This study evaluated efficacy of valnoctamide (racemic‐VCD), sec ‐butylpropylacetamide (racemic‐SPD), phenobarbital for stopping seizures both immature adult rats. Methods Female male postnatal day ( PND ) 21, 28, 70 (adult) rats, previously implanted with electroencephalography (EEG) electrodes were exposed seizure‐inducing doses agents sarin or VX EEG was recorded continuously....

10.1111/epi.14630 article EN Epilepsia 2019-01-07

3-Methylpentyl(4-sulphamoylphenyl)carbamate (MSPC) came as the most potent compound out of a new series carbamates composed phenyl-ethanol or branched aliphatic alcohols, and 4-benzenesulphonamide-carbamic acid. In this study, anticonvulsant activity pharmacokinetics (PKs) MSPC-two individual enantiomers were comparatively analysed in rats well their carbonic anhydrase (CA) inhibition. The MSPC was evaluated at rat-maximal electroshock (MES) test, CA inhibition evaluated. (R)-MSPC had 29%...

10.1080/14756366.2019.1612887 article EN cc-by Journal of Enzyme Inhibition and Medicinal Chemistry 2019-01-01

sec-Butylpropylacetamide (SPD) is the amide derivative of valproic acid (VPA). SPD possess a wide-spectrum anticonvulsant profile better than that VPA and blocks status epilepticus (SE) induced by pilocarpine organophosphates. The activity on SE benzodiazepines (BZDs) in terms ability to block when given 20-60 min after beginning seizure. However, intraperitoneal (i.p.) administration rats cannot be extrapolated humans. Consequently, current study comparative pharmacokinetic...

10.1021/acs.molpharmaceut.6b00221 article EN Molecular Pharmaceutics 2016-05-24

We recently reported a new class of carbamate derivatives as anticonvulsants. Among these, 3-methylpentyl(4-sulfamoylphenyl)carbamate (MSPC) stood out the most potent compound with ED50 values 13 mg/kg (i.p.) and 28 (p.o.) in rat maximal electroshock test (MES). 3-Methylpropyl(4-sulfamoylphenyl)carbamate (MBPC), characterized here, is an MSPC analogous two less aliphatic carbon atoms its structure. As both MBPC are chiral compounds, we studied carbonic anhydrase inhibitory anticonvulsant...

10.3390/ijms22073361 article EN International Journal of Molecular Sciences 2021-03-25

Abstract Objectives To advance the development of (2S,3S)‐ sec ‐butylpropylacetamide (SPD) as a new treatment for acute repetitive seizures (ARS), by studying its pharmacokinetics (PK) in pigs and PK‐pharmacodynamic (PK‐PD) correlation rats. Methods Two (2S,3S)‐SPD intramuscular formulations (F A F B ) were administered to rats blood samples withdrawn at different times after dosing. Major PK parameters estimated both species. PD analysis was conducted utilizing maximal‐electroshock seizure...

10.1111/epi.16411 article EN Epilepsia 2020-01-01

10.1016/s0761-8425(07)72474-9 article FR Revue des Maladies Respiratoires 2007-01-01
Coming Soon ...